UnitedHealth: Optum's Recovery Supports My Strong Buy Rating (NYSE:UNH)
UnitedHealth: Optum's Recovery Supports My Strong Buy Rating (NYSE:UNH) Seeking Alpha
Covered in this story
Analyst targets on UnitedHealth Group
- Baird: $389 → $427 by Oct 2027 · Neutral via GuruFocus
- TD Cowen: $379 → $402 by Oct 2027 via GuruFocus
- Cantor Fitzgerald: $379 → $495 by Sep 2027 · Overweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $UNH yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on UnitedHealth Group →Dalsna Finance is currently tracking 50 stories mentioning UnitedHealth Group, the earliest published 16 Jul 2026.
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.